Medicare Moves to Expand Coverage for Weight-Loss Drugs

“The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the blockbuster weight-loss drugs Wegovy and Zepbound,” Stat reports.

“Medicare currently covers the medications made by Novo Nordisk and Eli Lilly to treat diabetes and heart disease, but not for obesity alone because it’s prohibited by law from doing so. Given the price tag, a bill in Congress to extend coverage has stalled for years.”